logo-loader
viewSymphony Environmental Technologies PLC

Full interview: Symphony Environmental Technologies has game changing technology approved by U.S. FDA

Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology.

Laurier discusses what that means for the company and what their next steps are including what markets they plan on moving into.

Quick facts: Symphony Environmental Technologies PLC

Price: 26 GBX

AIM:SYM
Market: AIM
Market Cap: £44.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Symphony Environmental Technologies PLC named herein, including the promotion by the Company of Symphony Environmental Technologies PLC in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Symphony Environmental CEO talks coronavirus breakthrough for its...

Symphony Environmental Technologies PLC's (LON:SYM) Michael Laurier caught up with Proactive London's Andrew Scott after announcing its antimicrobial technology has been tested as effective against bovine coronavirus (COVID-19). A masterbatch was assessed by the lab group Eurofins, which...

2 weeks, 4 days ago

2 min read